Notice: This company has been marked as potentially delisted and may not be actively trading. Cinedigm (CIDM) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CIDM vs. BTX, ALFIW, and NLOKShould you be buying Cinedigm stock or one of its competitors? The main competitors of Cinedigm include Brooklyn ImmunoTherapeutics (BTX), Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Cinedigm vs. Brooklyn ImmunoTherapeutics Alfi NortonLifeLock Cinedigm (NASDAQ:CIDM) and Brooklyn ImmunoTherapeutics (NYSE:BTX) are both small-cap information companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends, community ranking and analyst recommendations. Which has higher valuation & earnings, CIDM or BTX? Brooklyn ImmunoTherapeutics has lower revenue, but higher earnings than Cinedigm. Cinedigm is trading at a lower price-to-earnings ratio than Brooklyn ImmunoTherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCinedigm$72.33M9.15-$9.35M-$0.05-70.80Brooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.19 Does the media favor CIDM or BTX? In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Cinedigm. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Cinedigm. Cinedigm's average media sentiment score of 0.00 equaled Brooklyn ImmunoTherapeutics'average media sentiment score. Company Overall Sentiment Cinedigm Neutral Brooklyn ImmunoTherapeutics Neutral Is CIDM or BTX more profitable? Company Net Margins Return on Equity Return on Assets CinedigmN/A N/A N/A Brooklyn ImmunoTherapeutics N/A N/A N/A Does the MarketBeat Community prefer CIDM or BTX? Cinedigm and Brooklyn ImmunoTherapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCinedigmOutperform VotesNo VotesUnderperform Votes65100.00% Brooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes103100.00% Do institutionals and insiders have more ownership in CIDM or BTX? 8.0% of Cinedigm shares are held by institutional investors. Comparatively, 26.0% of Brooklyn ImmunoTherapeutics shares are held by institutional investors. 16.4% of Cinedigm shares are held by insiders. Comparatively, 20.5% of Brooklyn ImmunoTherapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, CIDM or BTX? Cinedigm has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Comparatively, Brooklyn ImmunoTherapeutics has a beta of 4.61, indicating that its share price is 361% more volatile than the S&P 500. SummaryBrooklyn ImmunoTherapeutics beats Cinedigm on 5 of the 7 factors compared between the two stocks. Get Cinedigm News Delivered to You Automatically Sign up to receive the latest news and ratings for CIDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CIDM vs. The Competition Export to ExcelMetricCinedigmMotion Picture and Video Production IndustryInformation SectorNASDAQ ExchangeMarket Cap$661.68M$500.93M$5.27B$9.13BDividend YieldN/AN/A3.69%4.00%P/E Ratio-70.80N/A8.4917.53Price / Sales9.156.935.58134.37Price / CashN/AN/AN/A32.90Price / BookN/AN/AN/A4.69Net Income-$9.35MN/AN/A$224.57M Cinedigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CIDMCinedigmN/A$3.54+2.9%N/A+152.9%$661.68M$72.33M-70.80140Analyst ForecastBTXBrooklyn ImmunoTherapeuticsN/A$0.42-6.0%N/A-69.8%$24.84MN/A-0.19N/AGap DownHigh Trading VolumeALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040NLOKNortonLifeLock1.4636 of 5 stars$27.52+0.7%N/A+17.2%$15.72B$2.82B19.24N/A Related Companies and Tools Related Companies BTX Competitors ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CIDM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cinedigm Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Cinedigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CIDM Stock Alerts